Journal List > J Korean Med Assoc > v.54(10) > 1042352

J Korean Med Assoc. 2011 Oct;54(10):1028-1035. Korean.
Published online October 12, 2011.
Copyright © 2011 Korean Medical Association
Evidence-based National Cancer Screening program of Korea
Won-Chul Lee, MD
Department of Preventive Medicine, The Catholic University of Korea College of Medicine, Seoul, Korea.

Corresponding author: Won-Chul Lee, Email:
Received September 03, 2011; Accepted September 17, 2011.

This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.


Cancer is the leading cause of death in Korea. Therefore cancer control is one of the most important health issues. Cancer screening is the most promising strategy for controlling cancer. The National Cancer Screening Program started in 2002 in Korea. The goal of the program is to reduce the mortality or incidence rate of the cancer or both. To be effective, the evidence-based National Cancer Screening program should be implemented. For the evidence-based program, related indices were recommended for each step. When adopting a new cancer screening program, the predicted benefit and harm should be analysed, and when a decision is made to adopt the program, a pilot study for feasibility should be implemented. After implementing the community-based screening program, several types of the evaluation for the effectiveness of the program ought to be performed. The indices for each step were listed and discussed. And several conditions suggested for performing evidence-based national cancer screening program in Korea were discussed. Randomized clinical trials to compare the efficacy between the screening tools are recommended. And the study to evaluate the harm from the screening programs should be performed. To achieve the goal of the National Cancer Screening Program, evidence-based national cancer screening program should be performed.

Keywords: Evidence-based; National Cancer Screening Program; Mortality reduction; Harm

1. STATISTICS KOREA. Annual Report on the Causes of Death Statistics. Taejon: Statistical Office; 2011.
2. The Ministry of Health and Welfare. Cancer Control 2015 - 2nd period of 10 year plan for National Cancer Control. Seoul: 2006.
3. Mausner JS, Kramer S. In: Epidemiology: an introductory text. 2nd ed. Philadelphia: W. B. Saunders; 1985.
4. Wilson JMG, Jungner F. In: Principles and practice of screening for disease(Public Health Papers No. 34). Geneva: WHO; 1968.
5. The Ministry of Health and Welfare. Public Notification No. 2010-129 of the Ministry of Health and Welfare, Standard of National Cancer Screening Program. 2010.
6. Dowling EC, Klabunde C, Patnick J, Ballard-Barbash R. International Cancer Screening Network (ICSN). Breast and cervical cancer screening programme implementation in 16 countries. J Med Screen 2010;17:139–146.
7. Benson VS, Patnick J, Davies AK, Nadel MR, Smith RA, Atkin WS. International Colorectal Cancer Screening Network. Colorectal cancer screening: a comparison of 35 initiatives in 17 countries. Int J Cancer 2008;122:1357–1367.
8. Lee WC. Cancer Screening. In: Park JK, et al., editors. Oncology. Seoul: Ilchogak; 2003. pp. 246-249.
9. Heresbach D, Manfredi S, D'halluin PN, Bretagne JF, Branger B. Review in depth and meta-analysis of controlled trials on colorectal cancer screening by faecal occult blood test. Eur J Gastroenterol Hepatol 2006;18:427–433.
10. The Ministry of Health and Welfare. Public Notification No. 2010-120 of the Ministry of Health and Welfare, Standard of National Health Screening Program. 2010.
11. Fletcher SW, Black W, Harris R, Rimer BK, Shapiro S. Report of the International Workshop on Screening for Breast Cancer. J Natl Cancer Inst 1993;85:1644–1656.
12. English colorectal cancer screening pilot information pack [Internet]. Sheffield: NHS Cancer Screening Programmes; [cited 2011 Sep 19].
13. Shapiro S, Venet W, Strax P, Venet L, Roeser R. Ten- to fourteen-year effect of screening on breast cancer mortality. J Natl Cancer Inst 1982;69:349–355.
14. Kerlikowske K, Grady D, Rubin SM, Sandrock C, Ernster VL. Efficacy of screening mammography. A meta-analysis. JAMA 1995;273:149–154.
15. Andriole GL, Crawford ED, Grubb RL 3rd, Buys SS, Chia D, Church TR, Fouad MN, Gelmann EP, Kvale PA, Reding DJ, Weissfeld JL, Yokochi LA, O'Brien B, Clapp JD, Rathmell JM, Riley TL, Hayes RB, Kramer BS, Izmirlian G, Miller AB, Pinsky PF, Prorok PC, Gohagan JK, Berg CD. PLCO Project Team. Mortality results from a randomized prostate-cancer screening trial. N Engl J Med 2009;360:1310–1319.
16. Schroder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, Kwiatkowski M, Lujan M, Lilja H, Zappa M, Denis LJ, Recker F, Berenguer A, Maattanen L, Bangma CH, Aus G, Villers A, Rebillard X, van der Kwast T, Blijenberg BG, Moss SM, de Koning HJ, Auvinen A. ERSPC Investigators. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 2009;360:1320–1328.
17. Black WC. Overdiagnosis: an underrecognized cause of confusion and harm in cancer screening. J Natl Cancer Inst 2000;92:1280–1282.
18. Annual report of cancer statistics in Korea in 2008. Gyeonggi. Ministry of Health & Welfare, Korea Central Cancer Registry, National Cancer Center; 2010.
19. Taplin SH, Mandelson MT. Principles of cancer screening for clinicians. Prim Care 1992;19:513–533.
20. Schroder FH, Albertsen P. Open to debate. The motion: there is evidence that prostate cancer screening does more good than harm. Eur Urol 2006;50:377–380.
21. U.S. Preventive Services Task Force. Guide to clinical preventive services: report of the U.S. Preventive Services Task Force. Alexandria: International Medical Publishing; 2002.
22. NHS. Evaluation of the prostate cancer screening programme against the NSC handbook criteria. London: UK National Screening Committee; 2011.
23. Lazcano-Ponce EC, Moss S, Alonso de Ruiz P, Salmeron Castro J, Hernandez Avila M. Cervical cancer screening in developing countries: why is it ineffective? The case of Mexico. Arch Med Res 1999;30:240–250.
24. Vainio H, Bianchini F. In: IARC Handbooks of Cancer Prevention: Breast Cancer Screening. vol 7. LYON: IARC Press; 2002.
25. Yoon SH, Yim HW, Lee WC. Bias in cancer screening evaluation. Korean J Epidemiol 2008;30:12–24.
26. Lee SY, Lee WC, Koo JW, et al. Comparison of Sensitivity and Specificity between endoscopy and UGIS for stomach cancer screening; Annual Meeting for Society of Korean Preventive Medicine; Oct 25, 2001; Sokcho.
27. Park EC. Cost and effectiveness of National Cancer Control Program of Korea; the 30th Forum for cancer control; May 9, 2011; Seoul. National Cancer Center, the Ministry of Health and Welfare;
28. Ministry of Health & Welfare. whole Amended. Cancer Control Act. 2010 May 31. Act No.10333.
29. Ministry of Health & Welfare. Other Laws and Regulations Amended. Framework Act on Health Examination. 2010 May 31. Act No.10333.